MARX Biotech Co., Ltd. (TPEX:7731)
Taiwan · Delayed Price · Currency is TWD 4.310
+0.070 (1.65%)
Oct 8, 2026, 2:58 PM CST
MARX Biotech Market Cap
MARX Biotech has a market cap or net worth of 2.25 billion as of October 9, 2026. It is the 27,913th most valuable company in the world and the 1,595th biggest in Taiwan. Its market cap has increased by 3.40% in one year.
Market Cap
2.25B
Enterprise Value
2.40B
Revenue
584.74M
Global Rank
Country Rank
#1,595 Taiwan
PE Ratio
71.36
ChartMarket Cap Chart
Since February 5, 2024, MARX Biotech's market cap has decreased from 4.38B to 2.25B, a decrease of -48.67%. That is a compound annual growth rate of -22.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 2.25B | -7.75% |
| Dec 31, 2025 | 2.44B | -30.65% |
| Dec 31, 2024 | 3.52B | -19.77% |
| Feb 5, 2024 | 4.38B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 495.25B |
| Lin BioScience | 145.11B |
| Caliway Biopharmaceuticals | 120.54B |
| Heron Neutron Medical | 81.84B |
| HeXun Biosciences | 2.31B |
| PhytoHealth | 2.29B |
| Taiwan Bio Therapeutics | 2.28B |
| Gwo Xi Stem Cell Applied Technology Co. , | 2.28B |